Clover Health Investments Corp at Canaccord Genuity Growth Conference Transcript
All right. We're going to go ahead and kick off the conference this morning. Thank you for attending the Canaccord Genuity Growth Conference. I'm Richard Close. I head up the digital and tech-enabled health research here at Canaccord.
So we're kicking off this morning, I think the third year that Clover has been at our conference. And Clover competes in the Medicare Advantage area, also through the CMS ACO REACH program, really highlighted by bringing an innovative technology platform to lower costs and, more importantly, improve health outcomes. So from management, we have CEO, Andrew Toy, who took over last year; and then in the audience, CFO, Scott Leffler, too.
So Andrew, maybe just kicking off, you reported last night -- made me have a late night. So maybe we can just jump into that for a minute and set the table. Why don't you just give us a two-minute introduction to Clover: what the company does, why you do it. Then we'll get into the second-quarter report.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |